The present proceedings represent ideas and recommendations for conducting investigations of Controlled/Modified Release Products subjected to: Definitions, Pharmaceutical Characerization, In Vivo/In Vitro Association, Biopharmaceutical Characterization, e.g. Study Design, Main Variables, Single/Multiple Dosing Statistical Evaluation and Decision Criteria and Clinical Characterization of New and Known Drug Substances.